has reported Standalone financial results for the period ended September 30, 2022.
Financial Results (Q2 FY2023) - QoQ Comparison
The company has reported total income of Rs. 7.1144 crores during the period ended September 30, 2022 as compared to Rs. 5.1444 crores during the period ended June 30, 2022.
The company has posted net profit / (loss) of Rs. 0.0367 crores for the period ended September 30, 2022 as against net profit / (loss) of Rs. 0.3630 crores for the period ended June 30, 2022.
The company has reported EPS of Rs. 0.003 for the period ended September 30, 2022 as compared to Rs. 0.29 for the period ended June 30, 2022.
Total Income | ₹ 7.1144 crs | ₹5.1444 crs | 38.29% |
Net Profit | ₹0.0367 crs | ₹0.3630 crs | -89.89% |
EPS | ₹0.003 | ₹0.29 | -98.97% |
Financial Results (Q2 FY2023) - YoY Comparison The company has reported total income of Rs. 7.1144 crores during the period ended September 30, 2022 as compared to Rs.10.6233 crores during the period ended September 30, 2021.
The company has posted net profit / (loss) of Rs.0.0367 crores for the period ended September 30, 2022 as against net profit / (loss) of Rs.5.3997 crores for the period ended September 30, 2021.
The company has reported EPS of Rs.0.003 for the period ended September 30, 2022 as compared to Rs.4.38 for the period ended September 30, 2021.
Total Income | ₹ 7.1144 crs | ₹10.6233 crs | -33.03% |
Net Profit | ₹0.0367 crs | ₹5.3997 crs | -99.32% |
EPS | ₹0.003 | ₹4.38 | -99.93% |
Financial Results (Half Year Ended FY2023) - YoY Comparison The company has reported total income of Rs.12.2588 crores during the 6 Months period ended September 30, 2022 as compared to Rs.13.6934 crores during the 6 Months period ended September 30, 2021.
The company has posted net profit / (loss) of Rs.0.3997 crores for the 6 Months period ended September 30, 2022 as against net profit / (loss) of Rs.1.9867 crores for the 6 Months period ended September 30, 2021.
The company has reported EPS of Rs.0.03 for the 6 Months period ended September 30, 2022 as compared to Rs.1.56 for the 6 Months period ended September 30, 2021.
Total Income | ₹12.2588 crs | ₹13.6934 crs | -10.48% |
Net Profit | ₹0.3997 crs | ₹1.9867 crs | -79.88% |
EPS | ₹0.03 | ₹1.56 | -98.08% |
Source : Equity Bulls
Keywords
EarumPharmaceuticals
Q2FY23
H1FY23
ResultUpdate